Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Novel Bcl-2 specific inhibitor updated results confirm substantial activity and...

Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia

Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL ( Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )

Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise...

Dr Zafer Başlar - Istanbul University, Istanbul, Turkey

Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise patient safety? ( Dr Zafer Başlar - Istanbul University, Istanbul, Turkey )

Ibrutinib improves survival in CLL and SLL patients, RESONATE study shows

Prof Peter Hillmen - St James’ University Hospital, Leeds, UK

Ibrutinib improves survival in CLL and SLL patients, RESONATE study shows ( Prof Peter Hillmen - St James’ University Hospital, Leeds, UK )

LHRH analogue goserelin helps preserve fertility among women undergoing chemo...

Dr Halle Moore - Taussig Cancer Institute, Cleveland, USA

LHRH analogue goserelin helps preserve fertility among women undergoing chemo for hormone receptor-negative breast cancer ( Dr Halle Moore - Taussig Cancer Institute, Cleveland, USA )

Investigating anticarcinogenic compounds as an alternative to chemo

Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy

Investigating anticarcinogenic compounds as an alternative to chemo ( Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy )

Importance of oncology nurses' work and research to cancer care

Sarah Liptrott - Eurpean Institute of Oncology, Milan, Italy

Importance of oncology nurses' work and research to cancer care ( Sarah Liptrott - Eurpean Institute of Oncology, Milan, Italy )

Advances in diagnostic devices in melanoma screening

Dr Alessandro Testori - European Institute of Oncology, Milan, Italy

Advances in diagnostic devices in melanoma screening ( Dr Alessandro Testori - European Institute of Oncology, Milan, Italy )

KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second...

Prof Marc Peeters - University of Antwerp, Antwerp, Belgium

KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second-line treatment of mCC ( Prof Marc Peeters - University of Antwerp, Antwerp, Belgium )

Summary of breaking prostate news from ASCO 2014

Prof Eleni Efstathiou and Prof Gordon McVie

Summary of breaking prostate news from ASCO 2014 ( Prof Eleni Efstathiou and Prof Gordon McVie )

PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against...

Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, US

PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against metastatic melanoma ( Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, US )

Ipilimumab and nivolumab achieves long-term survival in advanced melanoma

Prof Mario Sznol - Yale Cancer Center, New Haven, USA

Ipilimumab and nivolumab achieves long-term survival in advanced melanoma ( Prof Mario Sznol - Yale Cancer Center, New Haven, USA )

Adjuvant ipilimumab improves recurrence-free survival in high-risk stage III...

Prof Alexander M. Eggermont, Erasmus University, Rotterdam, The Netherlands

Adjuvant ipilimumab improves recurrence-free survival in high-risk stage III melanoma ( Prof Alexander M. Eggermont, Erasmus University, Rotterdam, The Netherlands )

More from ecancer